Miller B E, Machemer T, Lehotan M, Heppner G H
E. Walter Albachten Department of Immunology, Michigan Cancer Foundation, Detroit 48201.
Cancer Res. 1991 Aug 15;51(16):4378-87.
Paired mixtures of melphalan-sensitive and relatively insensitive tumor cell subpopulation lines, originally derived from the same mammary tumor, were injected s.c. into syngeneic mice. When tumors were palpable, the mice were treated with melphalan at doses shown to be effective against the melphalan-sensitive subpopulations. Sensitivity was assessed by the loss of colony-forming ability of tumor cells harvested 1 to 14 days after treatment. When growing in tumors mixed with melphalan-sensitive line 4TO7 cells, line 66 (less sensitive) appeared much more sensitive than when it was grown alone. Line 66 tumors growing on the opposite sides of mice bearing line 4TO7 tumors were not more sensitive than when grown alone, indicating the lack of a systemic mechanism in the transfer of sensitivity from 4TO7 to 66. Furthermore, line 66 was not more sensitive when mixed with line 168TFAR (another melphalan-sensitive subpopulation) than when alone. The "transfer of sensitivity" from line 4TO7 to line 66 could be reproduced in collagen gel cultures but not in monolayer. Interestingly, line 4TO7, unlike line 168TFAR, is more sensitive to melphalan in collagen culture than in monolayer. This difference in sensitivity does not appear to be influenced by differences in cell density between the two culture systems. In collagen culture, the increased sensitivity of line 66 in the presence of line 4TO7 did not require cell contact and so appeared to act through diffusible factors(s). Collectively, these data suggest that the transfer of sensitivity is not dependent upon host factors or upon drug sensitivity per se but rather upon some mechanism requiring tumor cell-tumor cell interaction between specific subpopulation pairs. In additional studies, pH was ruled out as a factor in the transfer of sensitivity.
将最初源自同一乳腺肿瘤的美法仑敏感和相对不敏感的肿瘤细胞亚群系的配对混合物皮下注射到同基因小鼠体内。当肿瘤可触及后,用已证明对美法仑敏感亚群有效的剂量的美法仑对小鼠进行治疗。通过处理后1至14天收获的肿瘤细胞集落形成能力的丧失来评估敏感性。当与美法仑敏感的4TO7细胞系混合在肿瘤中生长时,66细胞系(敏感性较低)比单独生长时显得敏感得多。在携带4TO7肿瘤的小鼠对侧生长的66细胞系肿瘤并不比单独生长时更敏感,这表明不存在从4TO7向66传递敏感性的全身机制。此外,66细胞系与168TFAR细胞系(另一个美法仑敏感亚群)混合时并不比单独时更敏感。从4TO7细胞系到66细胞系的“敏感性转移”可以在胶原凝胶培养中重现,但不能在单层培养中重现。有趣的是,与168TFAR细胞系不同,4TO7细胞系在胶原培养中比在单层培养中对美法仑更敏感。这种敏感性差异似乎不受两种培养系统之间细胞密度差异的影响。在胶原培养中,66细胞系在4TO7细胞系存在时敏感性增加并不需要细胞接触,因此似乎是通过可扩散因子起作用。总体而言,这些数据表明敏感性转移不依赖于宿主因素或药物敏感性本身,而是依赖于某种需要特定亚群对之间肿瘤细胞-肿瘤细胞相互作用的机制。在进一步的研究中,pH被排除是敏感性转移的一个因素。